Adalta Ltd (1AD) - Cash Flow Conversion Efficiency

Latest as of December 2025: 2.240x

Based on the latest financial reports, Adalta Ltd (1AD) has a cash flow conversion efficiency ratio of 2.240x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-489.87K ≈ $-346.61K USD) by net assets (AU$-218.66K ≈ $-154.71K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Adalta Ltd to measure how many days the company can operate on defensive assets alone.

Adalta Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Adalta Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Adalta Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adalta Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Duoback Co. Ltd KQ:073190	-0.023x
Cardio Diagnostics Holdings Inc NASDAQ:CDIO	-0.195x
BetterLife Pharma Inc F:NPAU	0.030x
Americore Resources Corp. V:AMCO	-0.236x
Alfa Financial Software Holdings PLC LSE:ALFA	0.350x
Gencell Ltd TA:GNCL	-0.577x
Charger Metals NL AU:CHR	-0.019x
Pure Energy Minerals Ltd V:PE	0.000x

Annual Cash Flow Conversion Efficiency for Adalta Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Adalta Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 1AD market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-598.24K ≈ $-423.30K	AU$-2.94 Million ≈ $-2.08 Million	4.909x	+289.49%
2024-06-30	AU$2.03 Million ≈ $1.44 Million	AU$-5.26 Million ≈ $-3.72 Million	-2.590x	+3.59%
2023-06-30	AU$1.91 Million ≈ $1.35 Million	AU$-5.13 Million ≈ $-3.63 Million	-2.687x	-253.48%
2022-06-30	AU$5.38 Million ≈ $3.81 Million	AU$-4.09 Million ≈ $-2.89 Million	-0.760x	-1.52%
2021-06-30	AU$6.39 Million ≈ $4.52 Million	AU$-4.78 Million ≈ $-3.38 Million	-0.749x	+52.93%
2020-06-30	AU$3.70 Million ≈ $2.62 Million	AU$-5.89 Million ≈ $-4.17 Million	-1.591x	-104.89%
2019-06-30	AU$7.49 Million ≈ $5.30 Million	AU$-5.82 Million ≈ $-4.12 Million	-0.776x	+19.51%
2018-06-30	AU$4.07 Million ≈ $2.88 Million	AU$-3.93 Million ≈ $-2.78 Million	-0.965x	-100.48%
2017-06-30	AU$7.75 Million ≈ $5.48 Million	AU$-3.73 Million ≈ $-2.64 Million	-0.481x	-334.96%
2016-06-30	AU$10.62 Million ≈ $7.51 Million	AU$-1.17 Million ≈ $-830.93K	-0.111x	+94.35%
2015-06-30	AU$705.89K ≈ $499.46K	AU$-1.38 Million ≈ $-978.16K	-1.958x	+73.76%
2014-06-30	AU$172.82K ≈ $122.28K	AU$-1.29 Million ≈ $-912.79K	-7.465x	-219.41%
2013-06-30	AU$283.92K ≈ $200.89K	AU$-663.54K ≈ $-469.50K	-2.337x	--

About Adalta Ltd

AU:1AD Australia Biotechnology

Market Cap

$5.41 Million

AU$7.65 Million AUD

Market Cap Rank

#28401 Global

#1514 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.37